510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K760077Substantially Equivalent

Test, Ria, Serum Digoxin

Smithkline Diagnostics, Inc., Mchenry IL / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K760077 is the FDA 510(k) clearance record for TEST, RIA, SERUM DIGOXIN, a class II device, cleared for Smithkline Diagnostics, Inc. on under FDA product code DND (Radioimmunoassay, Digitoxin (125-I), Rabbit Antibody, Solid Phase Sep.). FDA records list 42 510(k) clearances for Smithkline Diagnostics, Inc., from to . As of , FDA records show no recalls naming K760077.

Clearance record

Decision date
Received
(28 days to decision)
Product code
DND Radioimmunoassay, Digitoxin (125-I), Rabbit Antibody, Solid Phase Sep.
Regulation
21 CFR 862.3300
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Smithkline Diagnostics, Inc. 803 N. Front St. Suite 3, Mchenry IL
Third party review
No

Clearances, product code DND

Trailing 12 months

FDA records hold no clearances under product code DND in the trailing twelve months.

FDA records show no clearances under product code DND in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code DND, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260